Ropivacaine Pharmacokinetics After Erector Spinae Block

Phase 4 Unknown 46 enrolled McGill University Health Centre/Research Institute of the McGill University Health Centre

RandomizedParallel-groupOpen-labelOther

Summary

The primary aim is to evaluate the analgesic efficacy of either technique by measuring cumulative morphine consumption in the first 24 hours after an erector spinae plane block with 2 ml/kg of ropivacaine 0.1% (2 ml/kg) or 1 ml/kg of ropivacaine 0.2%. The secondary aim of this study is to describe the pharmacokinetics of ropivacaine 0.1% and ropivacaine 0.2% after erector spinae block in children undergoing posterior spinal fusion.

Timeline

Start: 2023-06-01
Primary completion: 2024-03-01
Completion: 2024-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropivacaine	Other / unclassified	2 mg/kg	Other

Indications

No indication recorded.